G. Rojas

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2021, European journal of preventive cardiology.

Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

I. Amat-Santos, J. González-Juanatey, J. S. San Román, 2021, Cardiology journal.

The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

V. Ramos, I. Amat-Santos, J. González-Juanatey, 2020, Scientific Reports.

Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

I. Amat-Santos, J. González-Juanatey, J. S. San Román, 2022, Medicina Clínica (English Edition).

Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

I. Amat-Santos, J. González-Juanatey, J. S. San Román, 2021, Medicina Clínica.

Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities.

T. S. Chee, D. S. Kim, S. H. Lee, 2022, European journal of preventive cardiology.